Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection

Valerie J. Kinchen, Muhammad N. Zahid, Andrew I. Flyak, Mary G. Soliman, Gerald H. Learn, Shuyi Wang, Edgar Davidson, Benjamin J. Doranz, Stuart Campbell Ray, Andrea Cox, James E. Crowe, Pamela J. Bjorkman, George M. Shaw, Justin Bailey

Research output: Contribution to journalArticle

Abstract

The role that broadly neutralizing antibodies (bNAbs) play in natural clearance of human hepatitis C virus (HCV) infection and the underlying mechanisms remain unknown. Here, we investigate the mechanism by which bNAbs, isolated from two humans who spontaneously cleared HCV infection, contribute to HCV control. Using viral gene sequences amplified from longitudinal plasma of the two subjects, we found that these bNAbs, which target the front layer of the HCV envelope protein E2, neutralized most autologous HCV strains. Acquisition of resistance to bNAbs by some autologous strains was accompanied by progressive loss of E2 protein function, and temporally associated with HCV clearance. These data demonstrate that bNAbs can mediate clearance of human HCV infection by neutralizing infecting strains and driving escaped viruses to an unfit state. These immunopathologic events distinguish HCV from HIV-1 and suggest that development of an HCV vaccine may be achievable. Kinchen et al. demonstrate that antibodies isolated from humans who spontaneously cleared HCV infection blocked many different HCV strains. Viruses that evolved resistance to these antibodies lost the ability to replicate, suggesting that antibodies are important for HCV clearance, and an HCV vaccine may be attainable.

Original languageEnglish (US)
Pages (from-to)717-730.e5
JournalCell Host and Microbe
Volume24
Issue number5
DOIs
StatePublished - Nov 14 2018

Fingerprint

Virus Diseases
Neutralizing Antibodies
Hepacivirus
Vaccines
Viral Envelope Proteins
Viruses
Hepatitis C Antibodies
Viral Genes
Antibodies
HIV-1

Keywords

  • antibody specificity
  • binding sites
  • HCV clearance
  • hepatitis C virus
  • immunologic memory
  • neutralizing antibodies

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Virology

Cite this

Kinchen, V. J., Zahid, M. N., Flyak, A. I., Soliman, M. G., Learn, G. H., Wang, S., ... Bailey, J. (2018). Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. Cell Host and Microbe, 24(5), 717-730.e5. https://doi.org/10.1016/j.chom.2018.10.012

Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. / Kinchen, Valerie J.; Zahid, Muhammad N.; Flyak, Andrew I.; Soliman, Mary G.; Learn, Gerald H.; Wang, Shuyi; Davidson, Edgar; Doranz, Benjamin J.; Ray, Stuart Campbell; Cox, Andrea; Crowe, James E.; Bjorkman, Pamela J.; Shaw, George M.; Bailey, Justin.

In: Cell Host and Microbe, Vol. 24, No. 5, 14.11.2018, p. 717-730.e5.

Research output: Contribution to journalArticle

Kinchen, VJ, Zahid, MN, Flyak, AI, Soliman, MG, Learn, GH, Wang, S, Davidson, E, Doranz, BJ, Ray, SC, Cox, A, Crowe, JE, Bjorkman, PJ, Shaw, GM & Bailey, J 2018, 'Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection' Cell Host and Microbe, vol. 24, no. 5, pp. 717-730.e5. https://doi.org/10.1016/j.chom.2018.10.012
Kinchen VJ, Zahid MN, Flyak AI, Soliman MG, Learn GH, Wang S et al. Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. Cell Host and Microbe. 2018 Nov 14;24(5):717-730.e5. https://doi.org/10.1016/j.chom.2018.10.012
Kinchen, Valerie J. ; Zahid, Muhammad N. ; Flyak, Andrew I. ; Soliman, Mary G. ; Learn, Gerald H. ; Wang, Shuyi ; Davidson, Edgar ; Doranz, Benjamin J. ; Ray, Stuart Campbell ; Cox, Andrea ; Crowe, James E. ; Bjorkman, Pamela J. ; Shaw, George M. ; Bailey, Justin. / Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. In: Cell Host and Microbe. 2018 ; Vol. 24, No. 5. pp. 717-730.e5.
@article{f569713236ae4473b5796de6ed767c25,
title = "Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection",
abstract = "The role that broadly neutralizing antibodies (bNAbs) play in natural clearance of human hepatitis C virus (HCV) infection and the underlying mechanisms remain unknown. Here, we investigate the mechanism by which bNAbs, isolated from two humans who spontaneously cleared HCV infection, contribute to HCV control. Using viral gene sequences amplified from longitudinal plasma of the two subjects, we found that these bNAbs, which target the front layer of the HCV envelope protein E2, neutralized most autologous HCV strains. Acquisition of resistance to bNAbs by some autologous strains was accompanied by progressive loss of E2 protein function, and temporally associated with HCV clearance. These data demonstrate that bNAbs can mediate clearance of human HCV infection by neutralizing infecting strains and driving escaped viruses to an unfit state. These immunopathologic events distinguish HCV from HIV-1 and suggest that development of an HCV vaccine may be achievable. Kinchen et al. demonstrate that antibodies isolated from humans who spontaneously cleared HCV infection blocked many different HCV strains. Viruses that evolved resistance to these antibodies lost the ability to replicate, suggesting that antibodies are important for HCV clearance, and an HCV vaccine may be attainable.",
keywords = "antibody specificity, binding sites, HCV clearance, hepatitis C virus, immunologic memory, neutralizing antibodies",
author = "Kinchen, {Valerie J.} and Zahid, {Muhammad N.} and Flyak, {Andrew I.} and Soliman, {Mary G.} and Learn, {Gerald H.} and Shuyi Wang and Edgar Davidson and Doranz, {Benjamin J.} and Ray, {Stuart Campbell} and Andrea Cox and Crowe, {James E.} and Bjorkman, {Pamela J.} and Shaw, {George M.} and Justin Bailey",
year = "2018",
month = "11",
day = "14",
doi = "10.1016/j.chom.2018.10.012",
language = "English (US)",
volume = "24",
pages = "717--730.e5",
journal = "Cell Host and Microbe",
issn = "1931-3128",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection

AU - Kinchen, Valerie J.

AU - Zahid, Muhammad N.

AU - Flyak, Andrew I.

AU - Soliman, Mary G.

AU - Learn, Gerald H.

AU - Wang, Shuyi

AU - Davidson, Edgar

AU - Doranz, Benjamin J.

AU - Ray, Stuart Campbell

AU - Cox, Andrea

AU - Crowe, James E.

AU - Bjorkman, Pamela J.

AU - Shaw, George M.

AU - Bailey, Justin

PY - 2018/11/14

Y1 - 2018/11/14

N2 - The role that broadly neutralizing antibodies (bNAbs) play in natural clearance of human hepatitis C virus (HCV) infection and the underlying mechanisms remain unknown. Here, we investigate the mechanism by which bNAbs, isolated from two humans who spontaneously cleared HCV infection, contribute to HCV control. Using viral gene sequences amplified from longitudinal plasma of the two subjects, we found that these bNAbs, which target the front layer of the HCV envelope protein E2, neutralized most autologous HCV strains. Acquisition of resistance to bNAbs by some autologous strains was accompanied by progressive loss of E2 protein function, and temporally associated with HCV clearance. These data demonstrate that bNAbs can mediate clearance of human HCV infection by neutralizing infecting strains and driving escaped viruses to an unfit state. These immunopathologic events distinguish HCV from HIV-1 and suggest that development of an HCV vaccine may be achievable. Kinchen et al. demonstrate that antibodies isolated from humans who spontaneously cleared HCV infection blocked many different HCV strains. Viruses that evolved resistance to these antibodies lost the ability to replicate, suggesting that antibodies are important for HCV clearance, and an HCV vaccine may be attainable.

AB - The role that broadly neutralizing antibodies (bNAbs) play in natural clearance of human hepatitis C virus (HCV) infection and the underlying mechanisms remain unknown. Here, we investigate the mechanism by which bNAbs, isolated from two humans who spontaneously cleared HCV infection, contribute to HCV control. Using viral gene sequences amplified from longitudinal plasma of the two subjects, we found that these bNAbs, which target the front layer of the HCV envelope protein E2, neutralized most autologous HCV strains. Acquisition of resistance to bNAbs by some autologous strains was accompanied by progressive loss of E2 protein function, and temporally associated with HCV clearance. These data demonstrate that bNAbs can mediate clearance of human HCV infection by neutralizing infecting strains and driving escaped viruses to an unfit state. These immunopathologic events distinguish HCV from HIV-1 and suggest that development of an HCV vaccine may be achievable. Kinchen et al. demonstrate that antibodies isolated from humans who spontaneously cleared HCV infection blocked many different HCV strains. Viruses that evolved resistance to these antibodies lost the ability to replicate, suggesting that antibodies are important for HCV clearance, and an HCV vaccine may be attainable.

KW - antibody specificity

KW - binding sites

KW - HCV clearance

KW - hepatitis C virus

KW - immunologic memory

KW - neutralizing antibodies

UR - http://www.scopus.com/inward/record.url?scp=85055858735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055858735&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2018.10.012

DO - 10.1016/j.chom.2018.10.012

M3 - Article

VL - 24

SP - 717-730.e5

JO - Cell Host and Microbe

T2 - Cell Host and Microbe

JF - Cell Host and Microbe

SN - 1931-3128

IS - 5

ER -